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Passage through the digestive tract exposes Salmonella enterica to high concentrations of bile salts, powerful
detergents that disrupt biological membranes. Mutations in the wecD or wecA gene, both of which are involved
in the synthesis of enterobacterial common antigen (ECA), render S. enterica serovar Typhimurium sensitive
to the bile salt deoxycholate. Competitive infectivity analysis of wecD and wecA mutants in the mouse model
indicates that ECA is an important virulence factor for oral infection. In contrast, lack of ECA causes only a
slight decrease in Salmonella virulence during intraperitoneal infection. A tentative interpretation is that ECA
may contribute to Salmonella virulence by protecting the pathogen from bile salts.
Bile salts are detergent-like substances that aid in the diges-
tion and absorption of lipids. Bile salts are secreted from the
liver, stored in the gall bladder, and released through the bile
duct into the intestine during food passage. The most abundant
bile salts in humans are cholate and deoxycholate (DOC).
Enteric bacteria are intrinsically resistant to bile salts, due both
to the low permeability of the outer membrane bilayer to these
lipophilic solutes and to active efflux mechanisms. Mutations
that impair bile salt resistance in genes for lipopolysaccharide
(LPS) synthesis (14), tol genes (16), efflux pump genes (12, 22),
regulatory genes such as marAB (20) and phoPQ (25), and the
DNA adenine methyltransferase gene (8, 17) have been pre-
viously described.
Here we show that mutations in the wecD and wecA genes of
Salmonella enterica cause sensitivity to DOC. The wec gene
cluster is required for synthesis of the enterobacterial common
antigen (ECA), a glycolipid found in the external leaflet of the
outer membrane in all species of the family Enterobacteriaceae
(reviewed in reference 18). The ECA biosynthetic pathway is
diagrammed in Fig. 1. The polysaccharide portion of ECA
consists of a linear trimeric repeat with the following structure:
33)-D-Fuc4NAc-(134)--D-ManNAcA-(134)--D-GlcNAc-
(13, where Fuc4NAc is 4-acetamido-4,6-dideoxy-D-galactose,
ManNAcA is N-acetyl-D-mannosaminuronic acid, and GlcNAc
is N-acetyl-D-glucosamine. The initial step in the synthesis
of the repeat unit is the transfer of GlcNAc-1-phosphate
from UDP-GlcNAc to undecaprenyl monophosphate to yield
GlcNAc-pyrophosphorylundecaprenol (lipid I). The synthe-
sis of lipid I is followed by the successive incorporation of
ManNAcA and Fuc4NAc from the donors UDP-ManNAcA
and TDP-Fuc4NAc to form lipid II and lipid III, respectively.
Subsequent steps involve polymerization, transfer of the poly-
mer to a phospholipid aglycone, and translocation to the outer
membrane. Below we show that Salmonella mutants unable to
synthesize ECA are highly attenuated in oral infections and
slightly attenuated in intraperitoneal infections. Hence, we
propose that ECA plays a role in Salmonella virulence. Such a
role can be tentatively correlated with bile salt resistance.
MudJ mutagenesis identifies wecD as a locus necessary for
resistance to DOC. In an attempt to identify new genes poten-
tially involved in bile salt resistance in S. enterica serovar Ty-
phimurium, we performed a screen for mutants sensitive to
sodium deoxycholate in strain 14028, which is virulent in mice.
The strains used in this study are described in Table 1. MudJ
mutagenesis was achieved by the method of Hughes and Roth
(9). Five thousand Kmr colonies from 10 independent mu-
tagenesis trials were patched in grids onto Luria-Bertani (LB)
plates containing 1% DOC. Twenty-eight DOC-sensitive
(DOCs) isolates were obtained. Reconstruction experiments
showed that 19 of 28 DOCs isolates were resistant to lysis by
P22 HT phage. These are probably LPS mutants, since P22
adsorbs to the O antigen (15), and Escherichia coli mutants
lacking a complete O side chain in LPS (rough mutants) have
been shown to display bile salt sensitivity (14). In addition, 3
out of 14 Salmonella mutants sensitive to bile salts obtained by
Prouty et al. (16) had a rough LPS phenotype.
Chromosomal DNA from one DOCs P22-sensitive mutant
was prepared as previously described (4), digested with
BamHI, and ligated to plasmid pBluescript SK II(). Trans-
formants were selected on LB plates containing 40 g of kana-
mycin/ml. DNA sequencing with the MuL primer (23) revealed
that the insertion was located in wecD. This gene is part of the
wec gene cluster, which is involved in the biosynthesis and
assembly of ECA. Two lines of evidence confirmed that the
wecD mutant was sensitive to DOC. (i) Dilutions from expo-
nential cultures of the wecD mutant and the wild-type strain
were spread on LB plates supplemented with 1% DOC. Clear-
cut differences between the strains under study were found
(Fig. 2). (ii) The MIC of DOC was determined for each strain.
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For MIC determination, samples of 3  103 CFU/ml from
stationary-phase cultures were subjected to various concentra-
tions of DOC in polypropylene microtiter plates (Greiner,
Frickenhausen, Germany). After an overnight incubation at
37°C, the MIC for the wecD mutant was found to be 0.1%,
compared to 4% for the wild type.
DOC sensitivity of wec mutants is due to failure to synthe-
size ECA. Studies with E. coli have reported that null muta-
tions in wecE or wecF confer sensitivity to MacConkey agar
(which contains bile salts) and that this phenotype is caused by
accumulation of lipid II, an ECA biosynthetic intermediate (5).
According to the same study, the wecE wecA and wecF wecA
double mutants, which are unable to synthesize ECA but which
do not accumulate lipid II, are able to grow on MacConkey
agar. Results for the wecA single mutant were not shown in
that study (5). A wecD mutant can be also expected to accu-
mulate lipid II (Fig. 1). To investigate if the absence of ECA
without accumulation of lipid II could cause DOC sensitivity in
Salmonella, we tested a wecA mutant previously isolated in our
laboratory (6, 11). The MIC determined for the wecA mutant
was 0.2%, slightly higher than that for the wecD mutant but
well below the MIC for the wild type (Fig. 2). A nearly iden-
tical MIC for the wecD wecA double mutant was obtained (Fig.
2). These experiments suggest that in Salmonella the absence
of ECA, rather than the accumulation of lipid II, is the cause
of DOC sensitivity.
S. enterica wec mutants are severely attenuated in the mouse
model. During a natural infection, Salmonella encounters
DOC and other bile salts in the gut. Since wec mutants are
40-fold more sensitive to DOC than the wild type, we reasoned
that wec mutations might cause attenuation specifically in
orally inoculated mice. To test this hypothesis, 8-week-old fe-
male BALB/c mice (Charles River Laboratories, Santa Per-
petua de Mogoda, Spain) were subjected to mixed infections
with wec mutants. Groups of three or four animals were inoc-
FIG. 1. The ECA biosynthetic pathway (based on reference 2). Individual genetic loci are shown next to each enzymatic reaction. Genes
relevant for this work are boxed. Abbreviations: Und-P, undecaprenyl monophosphate; Glc, glucose; ManNAc, N-acetyl-D-mannosamine; Glc-1-P,
glucose 1-phosphate; FucNH2, 4-amino-4,6-dideoxy-D-glucose; Fuc4NAc, 4-acetamido-4,6-dideoxy-D-galactose; CoASH, coenzyme A; -KG,
-ketoglutaric acid; PPi, inorganic pyrophosphate.
TABLE 1. Strains used in this study
Strain Description Source
14028 Wild type ATCCb
TT10288 hisD9953::MudJ his-9944::MudI J. Roth
SV4429 wecD::MudJ This work
SV4759 wecA::Tn10dTet This worka
SV4801 wecD::MudJ wecA::Tn10dTet This work
a This mutant was constructed by P22 HT-mediated transduction of strain
14028 with a lysate from mutant SV2078 (6).
b ATCC, American Type Culture Collection.
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ulated with a 1:1 ratio of the mutant and the wild type. For oral
inoculation, bacteria were grown overnight at 37°C in LB with-
out shaking. For intraperitoneal inoculation, bacteria were
grown overnight at 37°C in LB with shaking, diluted into fresh
medium (1:100), and grown until an optical density at 600 nm
of 0.35 to 0.6 was reached. Oral inoculation was performed by
feeding the mice 25 l of saline containing 0.1% lactose and
108 bacteria. Intraperitoneal inoculation was performed with
0.2 ml of physiological saline containing 105 CFU. Bacteria
were recovered from the spleen 48 h after intraperitoneal
inoculation or 6 days after oral inoculation, and CFU were
enumerated on selective medium (LB with 40 g of kanamy-
cin/ml for wecD and 20 g of tetracycline/ml for wecA). A
competitive index (CI) for each mutant, the ratio between the
mutant and the wild-type strain in the output (bacteria recov-
ered from the host after infection) divided by their ratio in the
input (initial inoculum), was calculated (7, 21). The CI is a
sensitive measure of the relative degree of virulence attenua-
tion caused by a given mutation (3). wecD and wecA mutants
were significantly outcompeted by the wild-type strain in both
intraperitoneal and oral infections (Fig. 3). A detailed analysis
of the CIs obtained indicates that both mutants are slightly
attenuated in intraperitoneal infections (CI, 0.2 to 0.4) but
severely attenuated in oral infections (CI  0.005). The results
obtained after intraperitoneal inoculations are consistent with
an earlier report suggesting a small but significant difference in
virulence between ECA-producing and ECA-deficient strains
of S. enterica serovar Typhimurium (24). In that study, the
difference in 50% lethal doses was about 10-fold. A subsequent
study indicated that the apparently higher virulence of ECA-
positive strains was due to their increased survival in mice and
that this could be only partially attributed to their ECA-posi-
tive character (13). These data, together with the finding that
ECA does not possess endotoxin-like activity (10) and the
failure of anti-ECA antibodies to protect against salmonellosis
(19), prompted the view that ECA was not a significant deter-
minant of virulence (18). In contrast, our results with oral
infections show that wec genes have a significant role in viru-
lence. The different behaviors exhibited by wec mutants in oral
and intraperitoneal experiments are in agreement with the
hypothesis that ECA may be required for resistance to DOC in
the small intestine.
Different degrees of attenuation in wecD and wecA mutants.
The analysis of CIs of wec mutants against the wild-type strain
yields another interesting conclusion. Although both wecD and
wecA mutants were significantly outcompeted by the wild-type
strain in oral infections, the CI of the wecD mutant in oral
infections was lower than the CI of the wecA mutant. Statistical
FIG. 2. DOC sensitivity assay for wec mutants. Five-microliter portions of the appropriate dilutions of exponential cultures of the wild-type and
mutant strains were incubated for 24 h at 37°C in an LB plate (right) or an LB plate containing 1% DOC (left). The approximate numbers of
bacteria present in the original drops are indicated on the left of each plate.
FIG. 3. CI analysis for wecD and wecA mutants. Shown is a graph-
ical representation of CI analysis of strains carrying mutations in wecD,
wecA, or both genes, after intraperitoneal (ip) or oral infections. The
strains used in each mixed infection are indicated under the corre-
sponding bars. The CIs are the means from at least three infections.
Error bars represent the standard deviations. wt, wild-type strain.
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analysis (Student’s t test) showed that this difference was sig-
nificant (P  0.0009). In pursuit of a more precise comparison
of wecD and wecA mutants, we tested them in a direct-com-
petition experiment. The CI for the wecD mutant versus the
wecA mutant in oral infections was 0.39 (Fig. 3), and statistical
analysis indicates that this value is significantly different from 1
(P  0.0008). This result confirms that a wecD mutant is more
attenuated than a wecA mutant. One difference between these
mutants is that the wecD strain is expected to accumulate lipid
II (5) (Fig. 1). Altogether, these results suggest that ECA is an
important virulence factor per se and that the accumulation of
the lipid II intermediate might cause further attenuation. If
this hypothesis is correct, a double mutant carrying null muta-
tions in wecD and wecA should be as attenuated in oral infec-
tions as the wecA single mutant, since the double mutant does
not accumulate lipid II. To test this prediction, we constructed
a wecD wecA double mutant by P22 HT transduction and
determined the CI value for this strain versus the wild type.
Data shown in Table 2 and Fig. 3 indicate that the wecD wecA
double mutant is highly attenuated in oral infections. However,
the CI for this strain is significantly higher than the CI for the
wecD single mutant and not significantly different from the CI
for the wecA mutant (P values [Student’s t test] of 0.0034 and
0.0952, respectively). These data support the view that lack of
ECA causes a decrease in virulence and that a further decrease
occurs if lipid II is accumulated.
Role of ECA in Salmonella virulence. Despite the unique and
universal occurrence of ECA in the family Enterobacteriaceae,
its biological function remains unknown. Several lines of evi-
dence presented in this study support a role for ECA in both
the resistance to bile salts and the virulence of S. enterica
serovar Typhimurium in the mouse model. Our results also
suggest that both traits may be related, since the attenuation of
wec mutants is more significant in oral than in intraperitoneal
infections. A recent study (1) suggested that extracellular poly-
saccharides of uropathogenic E. coli are virulence determi-
nants in the murine urinary tract. However, the CI displayed by
a wecE mutant against the wild-type strain was not significantly
different from 1 (which indicates no attenuation) for the blad-
der or the kidney and around the limit of significance for the
urine (P  0.05) (1). In contrast, the CI’s displayed by S.
enterica wecA and wecD mutants are extremely low and statis-
tically significant, especially after oral inoculation (P 
0.0001). This high degree of attenuation is consistent with the
failure of wec mutants to resist the bactericidal effect of bile
salts. Neither defect can be attributed to the accumulation of
lipid II since a wecA mutant, in which lipid II does not accu-
mulate, is also attenuated in mice and sensitive to DOC.
This work was supported by grants QLRT-PL-00310 from the Eu-
ropean Union and BIO2001-0232-C02-02 from the Ministry of Science
and Technology of Spain. A stay of F.R.-M. at the Imperial College,
London, was partially supported by a grant from the Regional Gov-
ernment of Andalusia. F.R.-M. is an investigator of the Ramo´n y Cajal
program from the Ministry of Science and Technology of Spain.
REFERENCES
1. Bahrani-Mougeot, F. K., E. L. Buckles, C. V. Lockatell, J. R. Hebel, D. E.
Johnson, C. M. Tang, and M. S. Donnenberg. 2002. Type 1 fimbriae and
extracellular polysaccharides are preeminent uropathogenic Escherichia coli
virulence determinants in the murine urinary tract. Mol. Microbiol. 45:1079–
1093.
2. Barr, K., J. Klena, and P. D. Rick. 1999. The modality of enterobacterial
common antigen polysaccharide chain lengths is regulated by o349 of the wec
gene cluster of Escherichia coli K-12. J. Bacteriol. 181:6564–6568.
3. Beuzon, C. R., and D. W. Holden. 2001. Use of mixed infections with Sal-
monella strains to study virulence genes and their interactions in vivo. Mi-
crobes Infect. 3:1345–1352.
4. Cano, D. A., M. Martinez-Moya, M. G. Pucciarelli, E. A. Groisman, J.
Casadesus, and F. Garcia-Del Portillo. 2001. Salmonella enterica serovar
Typhimurium response involved in attenuation of pathogen intracellular
proliferation. Infect. Immun. 69:6463–6474.
5. Danese, P. N., G. R. Oliver, K. Barr, G. D. Bowman, P. D. Rick, and T. J.
Silhavy. 1998. Accumulation of the enterobacterial common antigen lipid II
biosynthetic intermediate stimulates degP transcription in Escherichia coli. J.
Bacteriol. 180:5875–5884.
6. Flores, A., and J. Casadesus. 1995. Suppression of the pleiotropic effects of
HisH and HisF overproduction identifies four novel loci on the Salmonella
typhimurium chromosome: osmH, sfiW, sfiX, and sfiY. J. Bacteriol. 177:4841–
4850.
7. Freter, R., P. C. O’Brien, and M. S. Macsai. 1981. Role of chemotaxis in the
association of motile bacteria with intestinal mucosa: in vivo studies. Infect.
Immun. 34:234–240.
8. Heithoff, D. M., E. Y. Enioutina, R. A. Daynes, R. L. Sinsheimer, D. A. Low,
and M. J. Mahan. 2001. Salmonella DNA adenine methylase mutants confer
cross-protective immunity. Infect. Immun. 69:6725–6730.
9. Hughes, K. T., and J. R. Roth. 1988. Transitory cis complementation: a
method for providing transposition functions to defective transposons. Ge-
netics 119:9–12.
10. Mayer, H., and G. Schmidt. 1979. Chemistry and biology of the enterobac-
terial common antigen (ECA). Curr. Top. Microbiol. Immunol. 85:99–153.
11. Mouslim, C., D. A. Cano, and J. Casadesus. 1998. The sfiX, rfe and metN
genes of Salmonella typhimurium and their involvement in the Hisc pleiotro-
pic response. Mol. Gen. Genet. 259:46–53.
12. Nikaido, H., M. Basina, V. Nguyen, and E. Y. Rosenberg. 1998. Multidrug
efflux pump AcrAB of Salmonella typhimurium excretes only those beta-
lactam antibiotics containing lipophilic side chains. J. Bacteriol. 180:4686–
4692.
13. Nnalue, N. A., and B. A. Stocker. 1987. The effects of O-antigen character
and enterobacterial common antigen content on the in vivo persistence of
aromatic-dependent Salmonella sp. live-vaccine strains. Microb. Pathog.
3:31–44.
14. Picken, R. N., and I. R. Beacham. 1977. Bacteriophage-resistant mutants of
Escherichia coli K-12. Location of receptors within the lipopolysaccharide.
J. Gen. Microbiol. 102:305–318.
15. Poteete, A. R. 1988. Bacteriophage P22, p. 647–682. In R. Calendar (ed.),
The bacteriophages, vol. 2. Plenum Press, New York, N.Y.
16. Prouty, A. M., J. C. Van Velkinburgh, and J. S. Gunn. 2002. Salmonella
enterica serovar Typhimurium resistance to bile: identification and charac-
terization of the tolQRA cluster. J. Bacteriol. 184:1270–1276.
17. Pucciarelli, M. G., A. I. Prieto, J. Casadesus, and F. Garcia-del Portillo.
2002. Envelope instability in DNA adenine methylase mutants of Salmonella
enterica. Microbiology 148:1171–1182.
18. Rick, P. D., and R. P. Silver. 1996. Enterobacterial common antigen and
capsular polysaccharides, p. 104–122. In F. C. Neidhardt, R. Curtiss III, J. L.
Ingraham, E. C. C. Lin, K. B. Low, B. Magasanik, W. S. Reznikoff, M. Riley,
M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella:
cellular and molecular biology, 2nd ed. ASM Press, Washington, D.C.
19. Saxe´n, H., and M. Hovi. 1985. The effect of antibodies to the enterobacterial
common antigen (ECA) on experimental mouse salmonellosis. FEMS Mi-
crobiol. Lett. 27:307–312.
20. Sulavik, M. C., M. Dazer, and P. F. Miller. 1997. The Salmonella typhi-
murium mar locus: molecular and genetic analyses and assessment of its role
in virulence. J. Bacteriol. 179:1857–1866.
21. Taylor, R. K., V. L. Miller, D. B. Furlong, and J. J. Mekalanos. 1987. Use of
TABLE 2. CIs for wecD and wecA mutants obtained in mixed
infections with the wild-type straina
Strain Mutant gene(s)
Intraperitoneal
inoculation Oral inoculation
CI P CI P
SV4429 wecD 0.39 0.0137 0.0007 0.0001
SV4759 wecA 0.27 0.0030 0.0046 0.0001
SV4801 wecD, wecA ND ND 0.003 0.0001
a P values were obtained by Student’s t test. The null hypothesis was a CI of 1.
A P value 0.05 indicates that CI is significantly different from 1. ND, not
determined.
VOL. 185, 2003 NOTES 5331
 o
n
 M
arch 1, 2016 by INSTITUTO
 DE PARASITO
LO
G
FA Y
http://jb.asm.org/
D
ow
nloaded from
 
phoA gene fusions to identify a pilus colonization factor coordinately regu-
lated with cholera toxin. Proc. Natl. Acad. Sci. USA 84:2833–2837.
22. Thanassi, D. G., L. W. Cheng, and H. Nikaido. 1997. Active efflux of bile salts
by Escherichia coli. J. Bacteriol. 179:2512–2518.
23. Torreblanca, J., and J. Casadesus. 1996. DNA adenine methylase mutants of
Salmonella typhimurium and a novel dam-regulated locus. Genetics 144:15–26.
24. Valtonen, M. V., U. M. Larinkari, M. Plosila, V. V. Valtonen, and P. H.
Makela. 1976. Effect of enterobacterial common antigen on mouse virulence
of Salmonella typhimurium. Infect. Immun. 13:1601–1605.
25. van Velkinburgh, J. C., and J. S. Gunn. 1999. PhoP-PhoQ-regulated loci are
required for enhanced bile resistance in Salmonella spp. Infect. Immun.
67:1614–1622.
5332 NOTES J. BACTERIOL.
 o
n
 M
arch 1, 2016 by INSTITUTO
 DE PARASITO
LO
G
FA Y
http://jb.asm.org/
D
ow
nloaded from
 
